Delivery Order SPE2DB20D1110-SPE2DB25FK07J
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,161.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMLODIPINE-VALSARTAN 10-160 MG 30S medication. The contract has a completion date of June 6, 2025 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.34 firm fixed-price delivery order is for the supply of AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, with a period of performance ending on November 1, 2024. This award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.39, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,761.26 firm fixed-price contract is for the delivery of AMLODIPINE-VALSARTAN 5-320 MG 30S, a cardiovascular medication, and has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMLODIPINE-VALSARTAN 10-320 MG 30S, a pharmaceutical product, with a ceiling value of $1,611.85 and a period of performance through June 17, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,108.06 firm fixed-price delivery order is for the provision of AMLODIPINE-VALSARTAN 5-320 MG 30S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of March 31, 2025 and was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.87 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, and has a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $2,837.70 contract is to provide AMLODIPINE-VALSARTAN 5-160 MG 30S medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...